drugset
drugset / Trial / NCT03660800

Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

NCT03660800 ↗

Phase 1 Completed 67 enrolled OPKO Health, Inc.
RandomizedParallel-groupOpen-labelBasic science

Summary

Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and non-Japanese Healthy Subjects

Timeline

Start
2018-08-20
Primary completion
2018-10-24
Completion
2019-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcifediol Unknown 450 ug Oral
Subject Calcifediol Unknown 900 ug Oral
Subject Calcifediol Unknown 1800 ug Oral

Indications

secondary hyperparathyroidism vitamin D deficiency